All terms in GO
| Label | Id | Description |
|---|---|---|
| GO_0150114 | GO_0150114 | |
| GO_0150113 | GO_0150113 | |
| negative regulation of cholesterol esterification | GO_0150110 |
Any process that stops, prevents or reduces the frequency, rate or extent of cholesterol esterification.
|
| GO_0150112 | GO_0150112 | |
| regulation of transepithelial transport | GO_0150111 |
Any process that modulates the frequency, rate or extent of transepithelial transport.
|
| glycine:proton antiporter activity | GO_0140799 |
Enables the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: glycine(out) + n H(+)(in) = glycine(in) + n H(+)(out).
|
| histone-arginine deiminase activity (H3-R26 specific) | GO_0140798 |
Catalysis of the reaction: H2O + histone 3 L-arginyl (position 26)= histone 3 L-citrullyl (position 26) + NH4+, resulting in histone H3 citrullination at position 26.
|
| histone-arginine deiminase activity (H3-R17 specific) | GO_0140797 |
Catalysis of the reaction: H2O + histone 3 L-arginyl (position 17)= histone 3 L-citrullyl (position 17) + NH4+, resulting in histone H3 citrullination at position 17.
|
| histone-arginine deiminase activity (H3-R8 specific) | GO_0140796 |
Catalysis of the reaction: H2O + histone 3 L-arginyl (position 8)= histone 3 L-citrullyl (position 8) + NH4+, resulting in histone H3 citrullination at position 8.
|
| (M)-viriditoxin biosynthetic process | GO_0140783 |
The chemical reactions and pathways resulting in the formation of (M)-viriditoxin, a fungal secondary metabolite with antibacterial activity.
|
| novofumigatonin biosynthetic process | GO_0140782 |
The chemical reactions and pathways resulting in the formation of novofumigatonin, a heavily oxygenated meroterpenoid containing a unique orthoester moiety.
|
| ilicicolin H biosynthetic process | GO_0140781 |
The chemical reactions and pathways resulting in the formation of ilicicolin H, a 4-hydroxy-2-pyridone alkaloid that has potent and broad antifungal activities by inhibiting the mitochondrial respiration chain.
|
| reactive gliosis | GO_0150103 |
A neuroinflammatory response, occurring over several days, during which glial cells undergo nonspecific reactive changes in response to damage to the central nervous system (CNS); typically involves the proliferation or hypertrophy of different types of glial cells.
|
| negative regulation of monocyte activation | GO_0150102 |
Any process that stops, prevents or reduces the frequency, rate or extent of monocyte activation.
|
| regulation of microtubule anchoring at centrosome | GO_0150101 |
Any process that modulates the frequency, rate or extent of microtubule anchoring at centrosome.
|
| GO_0150100 | GO_0150100 | |
| L-glutamate uniporter activity | GO_0140788 |
Catalysis of the active transport of a L-glutamate across a membrane by a mechanism involving conformational change, where energy for active transport is derived from membrane potential if the solute is charged.
|
| phosphate ion uniporter activity | GO_0140787 |
Catalysis of the active transport of a phosphate ion across a membrane by a mechanism involving conformational change, where energy for active transport is derived from membrane potential if the solute is charged.
|
| glutamine sensor activity | GO_0140786 |
Binding to and responding, e.g. by conformational change, to changes in the cellular level of glutamine.
|
| NAD-dependent protein demyristoylase activity | GO_0140773 |
Catalysis of the reaction: N6-tetradecanoyl-L-lysyl-[protein] + NAD(+) + H2O = tetradecanoyl-ADP-D-ribose + L-lysyl-[protein] + nicotinamide.
|